1. Home
  2. BGB vs CTKB Comparison

BGB vs CTKB Comparison

Compare BGB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

BGB

Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

HOLD

Current Price

$11.32

Market Cap

506.7M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.57

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGB
CTKB
Founded
2012
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
506.7M
541.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BGB
CTKB
Price
$11.32
$4.57
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
120.6K
2.2M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
9.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$7.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.67
52 Week Low
$10.85
$3.09
52 Week High
$12.65
$6.18

Technical Indicators

Market Signals
Indicator
BGB
CTKB
Relative Strength Index (RSI) 52.06 62.32
Support Level $11.29 $4.56
Resistance Level $11.36 $4.80
Average True Range (ATR) 0.05 0.22
MACD 0.00 0.07
Stochastic Oscillator 63.64 90.82

Price Performance

Historical Comparison
BGB
CTKB

About BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

Blackstone Strategic Credit Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: